Skip to main content

Table 3 Reinfection and recrudescence rate of Helicobacter pylori

From: Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy

Variable category

E B M T group

M E A group

p-value*

Recrudescence

(n = 60)

(n = 120)

 

  Yes

1 (1.7%)

4 (3.3%)

0.67

  No

59 (98.3%)

116 (96.7%)

 

Reinfection

(n = 59)

(n = 116)

 

  Yes

7 (11.9%)

19 (16.4%)

0.43

  No

52 (88.1%)

97 (83.6%)

 
  1. EBMT: esomeprazole (20 mg b.i.d), tripotassium dicitrate bismuthate (300 mg q.i.d), metronidazole (500 mg t.i.d), and tetracycline (500 mg q.i.d); MEA: moxifloxacin (400 mg q.d.), esomeprazole (20 mg b.i.d), and amoxicillin (1000 mg b.i.d.).
  2. * P-value for Pearson chi-square test or Fisher’s exact test for comparison of categorical data.